T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InterContinental Hotels Group PLC
NYSE:IHG
|
UK |
|
Kintor Pharmaceutical Ltd
HKEX:9939
|
CN |
|
R
|
Reino Capital SA
WSE:RNC
|
PL |
|
Water Intelligence PLC
LSE:WATR
|
US |
|
W
|
Wittchen SA
WSE:WTN
|
PL |
|
Inmyshow Digital Technology Group Co Ltd
SSE:600556
|
CN |
T Man Pharmaceutical PCL
Depreciation & Amortization
T Man Pharmaceutical PCL
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
Depreciation & Amortization
฿126.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Depreciation & Amortization
฿283.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Depreciation & Amortization
฿112m
|
CAGR 3-Years
43%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jack Chia Industries Thailand PCL
SET:JCT
|
Depreciation & Amortization
฿16.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
Depreciation & Amortization
฿69.5m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Depreciation & Amortization
฿60.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
T Man Pharmaceutical PCL
Glance View
T Man Pharmaceutical PCL is a TH-based company operating in industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-10-22. T.Man Pharmaceutical Public Company Limited is engaged in purchasing, importing, manufacturing, original equipment manufacturing, distributing and exporting of modern medicines, traditional medicine, dietary supplements, and health care products for the healthcare industry with subsidiaries as manufacturers. Its segments include manufactured products under own brand, manufactured products under third parties’ brand and trading products. With a diverse range of manufacturing machinery, it can produce various types of pharmaceutical products, meeting the needs of every consumer. Its production capabilities include tablets, capsules, powders, liquids, and semisolids. The company offers capsule products, including both hard and soft capsules in various sizes, all made with imported, high-quality raw materials. Its product range covers a wide range of diseases and comes in various forms, including uncoated tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, and suppositories.
See Also
What is T Man Pharmaceutical PCL's Depreciation & Amortization?
Depreciation & Amortization
126.1m
THB
Based on the financial report for Dec 31, 2025, T Man Pharmaceutical PCL's Depreciation & Amortization amounts to 126.1m THB.
What is T Man Pharmaceutical PCL's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
19%
Over the last year, the Depreciation & Amortization growth was 20%. The average annual Depreciation & Amortization growth rates for T Man Pharmaceutical PCL have been 19% over the past three years .